Antibodies News and Research

RSS
Rubella antibodies vs. COVID-19

Rubella antibodies vs. COVID-19

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Vaccine-induced antibody response to SARS-CoV-2 Omicron variant in patients with B cell malignancies with and without active B cell-targeted therapy

Study evaluates the effectiveness of lactobacilli throat sprays against COVID-19

Study evaluates the effectiveness of lactobacilli throat sprays against COVID-19

Maternal and infant antibody levels and transplacental transfer following SARS-CoV-2 infection and vaccination

Maternal and infant antibody levels and transplacental transfer following SARS-CoV-2 infection and vaccination

SARS-CoV-2 nanobody that binds to the receptor-binding domain could prevent  COVID-19 in animals

SARS-CoV-2 nanobody that binds to the receptor-binding domain could prevent COVID-19 in animals

Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

Early treatment of COVID-19 in high-risk children and adolescents infected with the Omicron variant of SARS-CoV-2

Waning antibody responses in SARS-CoV-2-infected or vaccinated population

Waning antibody responses in SARS-CoV-2-infected or vaccinated population

Research characterizes efficacy of various COVID vaccines against Omicron BA.1 and BA.2

Research characterizes efficacy of various COVID vaccines against Omicron BA.1 and BA.2

New research proves benefit of vaccination after recovery from COVID-19

New research proves benefit of vaccination after recovery from COVID-19

SARS-CoV-2 infection risk among dialysis patients during Omicron surge

SARS-CoV-2 infection risk among dialysis patients during Omicron surge

Association between seropositivity and comorbidities after COVID-19 vaccination

Association between seropositivity and comorbidities after COVID-19 vaccination

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

A circRNA COVID vaccine with potential to neutralize SARS-CoV-2 variants

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

Oral drug that reverses immune aging effectively prevents death in COVID-19 mouse model

New test greatly simplifies the diagnosis of allergies

New test greatly simplifies the diagnosis of allergies

Influence of vitamin D and age on first SARS-CoV-2 vaccine dose efficacy

Influence of vitamin D and age on first SARS-CoV-2 vaccine dose efficacy

Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents

Phase 2 trial evaluates the safety and immunogenicity of two doses of the SARS-CoV-2 vaccine MVC-COV1901 in adolescents

Safety and antibody responses to COVID-19 vaccines in an older community

Safety and antibody responses to COVID-19 vaccines in an older community

Study aimed to identify the direct pathway that associates integrins with vascular dysregulation during SARS-CoV-2 infection

Study aimed to identify the direct pathway that associates integrins with vascular dysregulation during SARS-CoV-2 infection

Neutralizing antibody responses against parental SARS-CoV-2 strain as well as against Omicron BA.1 and BA.2 variants

Neutralizing antibody responses against parental SARS-CoV-2 strain as well as against Omicron BA.1 and BA.2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.